Close Menu

ASMS

Movers & Shakers: Jun 10, 2011

Premium

Brandon Ruotolo, Frank Witney, Kevin King, Ronald DePinho, John Mendelsohn, Lynda Chin

Sales of the company's mass spec and LC platforms grew by more than 20 percent, as Life Science revenues rose to $464 million from $334 million a year ago.

At the Association for Mass Spectrometry's Applications to the Clinical Lab meeting this week, proteomics researchers highlighted the need for higher-throughput assays, with several introducing automated SISCAPA workflows employing instruments from vendors including Agilent Technologies and Thermo Fisher Scientific.

A Waters' official said the company's mass spec business was its "strongest performer across the line," while Bruker touted healthy growth in revenues and new orders in life sciences mass spec.

AB Sciex's new TripleTOF 5600 and Waters' new Xevo G2 QTof will enable researchers to run qualitative and quantitative workflows simultaneously, the companies said, allowing for full scans of complex samples that can then be interrogated in a more targeted fashion.

The anticipated weak mass-spec market has not stopped vendors from launching new instruments, which may pay off later in the year when spending from the economic stimulus package could hit instrument manufacturers.

The collaboration includes creating the Waters Centre for BioMedical Mass Spectrometry, which will serve to develop additional capabilities for the Synapt.

Industry Briefs: Mar 5, 2009

Premium

Bruker, NextGen, Sigma-Aldrich, Bio-Rad, Waters, Pressure BioSciences, PSI, Xencor, Pfizer

At ABRF’s annual conference this week, its various research groups presented preliminary results from their studies. One study found that clinical labs had trouble detecting PSA using standard ELISAs, which to some degree was a validation of proteomics.

The Danish liquid-chromatography and bioinformatics firm plans to use the funding to help it break even and build out its sales and marketing efforts.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.